Clinical trial
SGLT2-Inhibitors for Sleep Apnea in Heart Failure
NCT04640493
Study timeline
Study start (estimated)2023-12-01Date precision: month
Registry last updated2024-05-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Sleep Disordered Breathingunresolved
Interventions
DapagliflozinDRUG · verified · RxNorm: dapagliflozin
WatchPatDEVICE
Sponsors & collaborators
Columbia Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04640493 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.